SCHEMBL5580248

SCHEMBL5580248

C=C(C#N)C(=O)OCCCCCC(C)C

nearest known ligand 0.51

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.51
ALDH1A1 P00352 2/20 0.51
RARB P10826 1/20 0.33
TDP1 Q9NUW8 2/20 0.33
POLB P06746 1/20 0.33
APEX1 P27695 1/20 0.33
HTT P42858 1/20 0.33
CYP19A1 P11511 1/20 0.32
CYP3A4 P08684 1/20 0.32
DNM1 Q05193 1/20 0.31
KDM4C Q9H3R0 2/20 0.30
KDM4A O75164 1/20 0.30
PHF8 Q9UPP1 1/20 0.30
KDM2A Q9Y2K7 1/20 0.30
NAAA Q02083 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15519654 1.00 TSHR (0.51) TSHRALDH1A1RARBTDP1POLB
SCHEMBL4578805 1.00 TSHR (0.51) TSHRALDH1A1RARBTDP1POLB
SCHEMBL4621788 1.00 TSHR (0.51) TSHRALDH1A1RARBTDP1POLB
SCHEMBL15520522 1.00 TSHR (0.51) TSHRALDH1A1RARBTDP1POLB
SCHEMBL21932806 1.00 TSHR (0.51) TSHRALDH1A1RARBTDP1POLB
SCHEMBL1924506 0.98 TSHR (0.53) TSHRALDH1A1RARBTDP1POLB
SCHEMBL316485 0.93 TSHR (0.55) TSHRALDH1A1TDP1CYP19A1DNM1
Isopentyl 2-Cyanoacrylate SCHEMBL450802 0.86 TSHR (0.58) TSHRALDH1A1TDP1CYP19A1
SCHEMBL11672299 0.86 TSHR (0.61) TSHRALDH1A1TDP1POLBAPEX1
SCHEMBL1982599 0.86 TSHR (0.61) TSHRALDH1A1TDP1POLBAPEX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026104704-A1 A COMBINATION, MEDICAL KIT AND MEDICAL DEVICE FOR TREATING AND/OR PREVENTING TISSUE LEAKAGE FUNDACIÓ INSTITUT DE INVESTIGACIÓ EN CIÈNCIES DE LA SALUT GERMANS TRIAS I PUJOL (ES) 2026-05-21 WO claimed
EP-4744687-A1 A COMBINATION, MEDICAL KIT AND MEDICAL DEVICE FOR TREATING AND/OR PREVENTING TISSUE LEAKAGE Aesculap AG (DE) 2026-05-20 EP claimed
CN-118846192-A Low-irritation sterilization medical adhesive and preparation method thereof 卫纳塞德(北京)医疗科技有限公司 2024-10-29 CN claimed
CN-117717645-A Vein adhesive suitable for terminal sterilization and preparation method thereof 浙江伽奈维医疗科技有限公司 2024-03-19 CN claimed
CN-117582703-A Filtering process of cyanoacrylate adhesive 浙江伽奈维医疗科技有限公司 2024-02-23 CN claimed
CN-117511418-A Self-grafting mascara 青岛爱蕾诗假睫毛有限公司 2024-02-06 CN claimed
CN-117462729-A Polycyanoacrylic acid-cyanoacrylate embolism microsphere, preparation method and application thereof 北京康派特医疗器械有限公司 2024-01-30 CN claimed
CN-117427204-A Modified medical adhesive and preparation method and application thereof 北京康派特医疗器械有限公司 2024-01-23 CN claimed
CN-117427205-A Modified medical adhesive composition and preparation method and application thereof 北京康派特医疗器械有限公司 2024-01-23 CN claimed
CN-112826976-B Preparation of low-whitening cyanoacrylate medical adhesive 江西博恩锐尔生物科技有限公司 2024-01-16 CN claimed
US-20150361314-A1 ADHESIVE BEADS DRY CAROLYN M (US) 2015-12-17 US claimed
EP-2951256-A1 ADHESIVE BEADS Dry, Carolyn M. (US) 2015-12-09 EP claimed
WO-2014121223-A1 ADHESIVE BEADS DRY CAROLYN M (US) 2014-08-07 WO claimed
US-6849082-B2 Method for curing cyanoacrylate adhesives SPARTAN PRODUCTS INC. (US) 2005-02-01 US claimed
US-20030077386-A1 Method for curing cyanoacrylate adhesives ADHEZION BIOMEDICAL, LLC 2003-04-24 US claimed
US-20020065314-A1 COMPOSITIONS AND METHOD FOR STIMULATING HAIR GROWTH S.N. BIOTECH, INC. 2002-05-30 US claimed
EP-0824316-A4 COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH NIELSEN THOR B (US) 2001-01-17 EP claimed
US-5767152-A USING A CYANOCARBOXYLIC ACID S.N. BIOTECH, INC. 1998-06-16 US claimed
EP-0824316-A1 COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH Nielsen, Thor, B. (US) 1998-02-25 EP claimed
WO-1996034526-A1 COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH NIELSEN THOR B (US) 1996-11-07 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020065314-A1 COMPOSITIONS AND METHOD FOR STIMULATING HAIR GROWTH AREG, NGF, HDGF TSHR 148/4885ALDH1A1 3677/4885RARB 95/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.